Funds large, patient-centered clinical effectiveness research on menopause, maternal sleep health, and ADRD mental health, emphasizing rigorous, real-world studies with strong patient and stakeholder engagement.
Funder: Patient-Centered Outcomes Research Institute
Due Dates (Anticipated): September 2026 (Letter of Intent) | January 2027 (Full Application)
Funding Amounts: Up to $120 million total; individual projects: Category 1 ≤ $5M direct costs, Category 2/3 up to $12M direct costs; up to 5 years/project.
Summary: Supports high-impact, patient-centered comparative clinical effectiveness research, with emphasis on menopause, maternal sleep health, and ADRD mental health.
Key Information: This is a forecasted opportunity—dates are projected based on annual cycles.
This Patient-Centered Outcomes Research Institute (PCORI) funding opportunity supports large, pragmatic, patient-centered comparative clinical effectiveness research (CER) projects. The program encourages rigorous studies—preferably individual or cluster randomized controlled trials, but well-designed natural experiments and observational studies are also eligible—that address clinically meaningful questions and outcomes important to patients and stakeholders. Research should be designed for real-world impact and facilitate the widespread uptake of findings, including through hybrid effectiveness-implementation approaches.
For this cycle, PCORI highlights three Special Areas of Emphasis (SAEs):
Projects outside these areas are also welcome, as long as they align with PCORI's broad mission of patient-centered CER. All applications must include meaningful patient and stakeholder engagement throughout the research process, following PCORI’s Foundational Expectations for Partnerships in Research.